In the last trading session, 3.84 million shares of the Sana Biotechnology Inc (NASDAQ:SANA) were traded, and its beta was 1.56. Most recently the company’s share price was $7.56, and it changed around $0.06 or 0.80% from the last close, which brings the market valuation of the company to $1.67B. SANA currently trades at a discount to its 52-week high of $12.00, offering almost -58.73% off that amount. The share price’s 52-week low was $2.74, which indicates that the current value has risen by an impressive 63.76% since then. We note from Sana Biotechnology Inc’s average daily trading volume that its 3-month average coming to 2.03 million.
Sana Biotechnology Inc (NASDAQ:SANA) trade information
Instantly SANA has showed a green trend with a performance of 0.80% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently up 85.29% year-to-date, but still down -27.59% over the last five days. On the other hand, Sana Biotechnology Inc (NASDAQ:SANA) is -19.23% down in the 30-day period.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The consensus price target as assigned by Wall Street analysts is $12, which translates to bulls needing to increase their stock price by 37.0% from its current value. Analyst projections state that SANA is forecast to be at a low of $12 and a high of $12.
Sana Biotechnology Inc (SANA) estimates and forecasts
Sana Biotechnology Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 126.35 percent over the past six months and at a 34.97% annual growth rate that is well above the industry average of 12.90%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -83.13%.
